Alliqua BioMedical, Inc. (ALQA) financial statements (2020 and earlier)

Company profile

Business Address 100 PINE ST., STE. 500
SAN FRANCISCO, CA 94111
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 926261712
Cash and cash equivalents 926261712
Receivables 033   
Inventory, net of allowances, customer advances and progress billings 023311
Inventory 023311
Disposal group, including discontinued operation 00    
Other undisclosed current assets 001310
Total current assets: 9712332013
Noncurrent Assets
Property, plant and equipment 022212
Intangible assets, net (including goodwill)  24405583
Goodwill  2122140
Intangible assets, net (excluding goodwill)  22283442
Other noncurrent assets 000000
Total noncurrent assets: 0254357105
TOTAL ASSETS: 103354903017
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 168652
Accounts payable 123321
Accrued liabilities 045321
Employee-related liabilities     2 
Debt  1112   
Derivative instruments and hedges, liabilities 000101
Disposal group, including discontinued operation 0     
Business combination, contingent consideration, liability   15 
Other liabilities      0
Other undisclosed current liabilities     (2)0
Total current liabilities: 117201243
Noncurrent Liabilities
Long-term debt and lease obligation 000120 
Long-term debt, excluding current maturities 000120 
Liabilities, other than long-term debt   21300
Deferred tax liabilities, net  1100
Business combination, contingent consideration, liability   112 
Other undisclosed noncurrent liabilities    030
Total noncurrent liabilities: 0022630
Total liabilities: 117223773
Stockholders' equity
Stockholders' equity attributable to parent 81632522314
Common stock 000000
Additional paid in capital 1671661561489359
Accumulated deficit (158)(150)(124)(96)(70)(45)
Total stockholders' equity: 81632522314
TOTAL LIABILITIES AND EQUITY: 103354903017

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 220181552
Revenue, net382500 
Cost of revenue (2)(7)(7)(6)(3)(2)
Financial services costs1(1)   
Gross profit: 0131292(0)
Operating expenses (6)(39)(43)(37)(27)(20)
Operating loss: (5)(26)(31)(28)(25)(20)
Nonoperating income (expense) (2)(2)(2)1(0)(2)
Investment income, nonoperating 0 0000
Debt instrument, convertible, beneficial conversion feature     11
Interest and debt expense (2)(0)(0)(2)(0)(0)
Loss from continuing operations before equity method investments, income taxes: (9)(29)(33)(29)(25)(22)
Other undisclosed income from continuing operations before income taxes 20020 
Loss from continuing operations before income taxes: (7)(29)(33)(28)(25)(22)
Income tax expense (benefit)  112(0)(0)
Loss from continuing operations: (7)(28)(32)(26)(25)(22)
Loss from discontinued operations (7)     
Net loss: (14)(28)(32)(26)(25)(22)
Other undisclosed net income attributable to parent 524  0
Net loss attributable to parent: (8)(26)(28)(26)(25)(22)
Preferred stock dividends and other adjustments      (0)
Net loss available to common stockholders, diluted: (8)(26)(28)(26)(25)(22)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss: (14)(28)(32)(26)(25)(22)
Comprehensive loss, net of tax, attributable to parent: (14)(28)(32)(26)(25)(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: